Vivus Inc has announced that Actavis Plc plans to market a generic version of Qsymia (phentermine plus topiramate).Actavis has already...
Actavis plc announced that it has launched its generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) 0.25 and 0.5...
Actavis plc , a leading global specialty pharmaceutical company, and Durata Therapeutics, Inc. , an innovative pharmaceutical company focused on...
Actavis plc and Gedeon Richter Plc have announced that the FDA has acknowledged receipt of Actavis' New Drug Application (NDA)...
Actavis plc has confirmed that the FDA Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval...
Actavis plc announced that the company has adopted Allergan plc as its new global name and will begin trading today...
Actavis plc announced that it will adopt a new corporate name - Allergan - following the anticipated successful completion of...
Actavis plc confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market...
Actavis and Medicines360 have announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the FDA for use by women to...
The FDA has accepted for filing Actavis' supplemental New Drug Application (sNDA) to expand the label for Teflaro (ceftaroline fosamil)...